BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.1304
-0.0042 (-3.12%)
At close: Apr 2, 2026, 4:00 PM EDT
0.1300
-0.0004 (-0.31%)
After-hours: Apr 2, 2026, 7:40 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $10.8 million as of April 2, 2026. Its market cap has decreased by -47.70% in one year.
Market Cap
10.80M
Enterprise Value
9.89M
1-Year Change
-47.70%
Ranking
Category
Stock Price
$0.13
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $10.80M, a decrease of -98.13%. That is a compound annual growth rate of -52.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 10.80M | -67.77% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 14.86M |
| Traws Pharma | 14.62M |
| IN8bio | 14.48M |
| Phio Pharmaceuticals | 14.17M |
| Cocrystal Pharma | 13.92M |
| Hoth Therapeutics | 13.66M |
| BioCardia | 13.02M |
| GT Biopharma | 12.88M |